Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Integra Therapeutics logo — Integra Therapeutics is a biotech company engineering the ne...

Integra Therapeutics

Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases

Founded 2020 Spain Spain 23 employees Seed Total: $19.20M Biotechnology, Health Care +1

General Information

Company Name Integra Therapeutics
Founded Year 2020
Location Spain Spain
Employees 23
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Business Model B2B, Platform, B2B2C
Revenue Model Licensing, Performance Based, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Integra Therapeutics. To contact Integra Therapeutics, visit integra-tx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Integra Therapeutics compare?

A PDF of Integra Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Integra Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Integra Therapeutics

Integra Therapeutics, founded in 2020, is a pioneering biotech company headquartered in Spain. With the slogan, "Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases," the company is at the forefront of developing cutting-edge gene writing technology.

Integra Therapeutics has ingeniously combined the well-documented precision of CRISPR systems with the exceptional gene transfer efficiency offered by viral integrases and transposases. This fusion of advanced technologies allows the company to precisely and efficiently integrate large DNA sequences into genomes, marking a breakthrough in programmable gene delivery.

Recently, the company reinforced its stronghold in the industry with a €10.70M seed investment round on 01 September 2025. Notable investors include Columbus Venture Partners, Takeda Ventures, Invivo Partners, AdBio partners, EIC Fund, and CDTI Innvierte, showcasing significant confidence in Integra Therapeutics' potential to revolutionize genetic therapies.

Business keywords: Gene Editing, CRISPR Technology, Gene Writing Tools, Genetic Diseases, DNA Binding Proteins, Viral Integrases, Transposases, Genome Engineering, Gene Transfer Efficiency, Programmable Gene Delivery, Precision Medicine, Therapeutic Development, Biotech Innovation

Services & Products

Development of gene writing tools
Improving gene therapy scope and efficiency
Advancing oncological and autoimmune therapies

Target Customers

Biopharmaceutical companies Medical researchers Oncologists Healthcare providers specializing in autoimmune diseases

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €10.70M 6
Columbus Venture Partners Takeda Ventures Invivo Partners
Columbus Venture Partners, Takeda Ventures +4
01 Sep 2025
Support Program Undisclosed 1
EIT Health
01 Jan 2025
Grant $2.50M 1
EIC Fund
01 Mar 2024
Support Program Undisclosed 1
EIT Health
01 Jan 2023
Seed €1.50M 1
Columbus Venture Partners
Columbus Venture Partners
01 Mar 2022
Seed €4.50M 3
Invivo Partners
Invivo Partners, AdBio partners +1
01 Dec 2021
Support Program Undisclosed 1
EIT Health
01 Jan 2021
Spinout Undisclosed 1
University Ventures
University Ventures
01 Jan 2020

Latest News

View All
Integra Therapeutics raises €10.7M to advance FiCAT platform and CAR-T validation — Tech
Integra Therapeutics raises €10.7M to advance FiCAT platform and CAR-T validation
Tech Sep 08, 2025
Integra Therapeutics receives EIC Accelerator funds of up to €10.5M for gene writing tools — Tech
Integra Therapeutics receives EIC Accelerator funds of up to €10.5M for gene writing tools
Tech Jul 17, 2024

Integra Therapeutics Alternatives & Competitors

View All Alternatives
Integra Therapeutics vs
EmendoBio
EmendoBio United States

Making any gene targetable

Corporate Round
41 employees
Biotechnology, Health Care
Integra Therapeutics vs
Hunterian Medicine
Hunterian Medicine United States

Advancing cures for genetic diseases with innovative CRISPR delivery technology

Grant
6 employees
Biotechnology, Health Care
Integra Therapeutics vs
Excision BioTherapeutics
Excision BioTherapeutics United States

Developing CRISPR-based therapies intended to cure viral infectious diseases.

Grant
24 employees
Biotechnology, Health Care
View all alternatives

FAQ About Integra Therapeutics

Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases
Integra Therapeutics was founded in 2020.
Integra Therapeutics is headquartered in Spain.
Integra Therapeutics operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Gene Editing, CRISPR Technology, Gene Writing Tools and Genetic Diseases. Its customers include Biopharmaceutical companies, Medical researchers and Oncologists.
Integra Therapeutics has a B2B, Platform and B2B2C business model. Its revenue comes from Licensing, Performance Based and Project Based.
Integra Therapeutics has approximately 23 employees.
Integra Therapeutics has completed 8 funding rounds, raising a total of $19.20M. The latest funding stage is Seed.
Integra Therapeutics offers: Development of gene writing tools, Improving gene therapy scope and efficiency, Advancing oncological and autoimmune therapies.
Top alternatives and competitors to Integra Therapeutics include EmendoBio, Hunterian Medicine, Excision BioTherapeutics, Full Circles Therapeutics Inc., Amber Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Integra Therapeutics and EmendoBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Integra Therapeutics, https://bouncewatch.com/company/integra-therapeutics, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes